Medicine and Dentistry
Human Immunodeficiency Virus
100%
Antiretroviral Therapy
30%
Cohort Analysis
21%
Infection
18%
Human Immunodeficiency Virus Infection
15%
Antivirus Agent
13%
Hepatitis C Virus
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Retrospective Cohort Study
12%
Periodontitis
12%
Men Who Have Sex with Men
10%
Prospective Cohort Study
10%
Dolutegravir
8%
Reverse-Transcriptase Inhibitor
7%
Cell Count
7%
Systematic Review
7%
Monotherapy
7%
Immunogenicity
7%
Physical Examination
7%
Malignant Neoplasm
7%
Lamivudine
7%
Hepatitis C
7%
Cardiovascular Disease
7%
Disease
6%
Drug Therapy
5%
Symptom
5%
Outpatient
5%
Tenofovir
5%
Mixed Infection
5%
Hepatitis B Virus
5%
Venous Thromboembolism
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
97%
Cohort Study
21%
Infection
17%
Antivirus Agent
15%
Acute Hepatitis C
15%
Hepatitis C Virus
14%
Hepatitis C
13%
Proteinase Inhibitor
12%
Dolutegravir
11%
Prospective Cohort Study
11%
Monotherapy
11%
Ritonavir
11%
Human Immunodeficiency Virus Infection
9%
RNA Directed DNA Polymerase Inhibitor
8%
Immunogenicity
7%
Darunavir
7%
Lopinavir
7%
Malignant Neoplasm
7%
Lamivudine
7%
Immune Reconstitution Inflammatory Syndrome
5%
Disease
5%
SARS Coronavirus
5%
Randomized Controlled Trial
5%
Tenofovir
5%
Inflammation
5%
Venous Thromboembolism
5%
Keyphrases
Netherlands
20%
People Living with HIV (PLHIV)
15%
AIDS/HIV
11%
HIV Infection
8%
HIV Patients
8%
Retrospective Cohort Study
8%
Venous Thromboembolic Events
7%
Immunogenicity
7%
Periodontitis
6%
Severe Periodontitis
5%
Combined Antiretroviral Therapy (cART)
5%
COVIDSurg
5%
